(Q35183905)

7 August 2017

1 reference

title

Post-market surveillance of GM foods: applicability and limitations of schemes used with pharmaceuticals and some non-GM novel foods (English)

1 reference

7 August 2017

Wal JM

1

1 reference

7 August 2017

Hepburn PA

series ordinal

2

1 reference

7 August 2017

Lea LJ

series ordinal

3

1 reference

7 August 2017

Crevel RW

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Regulatory Toxicology and Pharmacology

7 August 2017

1 reference

7 August 2017

38

1 reference

7 August 2017

98-104

1 reference

7 August 2017

1

1 reference

A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900079-5

7 January 2021

Olestra Postmarketing Surveillance Study: design and baseline results from the sentinel site.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900079-5

7 January 2021

Alert systems for post-marketing surveillance of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900079-5

7 January 2021

Immediate allergic reactions after vaccinations--a post-marketing surveillance review

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900079-5

7 January 2021

10.1016/S0273-2300(03)00079-5

Identifiers

DOI

1 reference

7 August 2017

1 reference